Every day, hundreds of thousands of commuters across the country travel from houses, apartments and other residential spaces to commercial buildings — from offices and schools to gyms and grocery stores.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.